Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an Orphan Drug for the treatment...
Search results for "tumor response rate"
"Breast Cancer Diagnosis, It's Too Early to Give Up" A Doctor's Calm Comfort
"Many breast cancer patients struggle with the process of fighting the disease. This is likely due to the thought that they have to give up a lot as...
Stomach Cancer Immunotherapy: Different Effects on Men and Women... Effective for Men, but 'Not So Much' for Women
A study has revealed that the therapeutic effects of 'immune checkpoint inhibitors ', which are gaining attention as...
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears
Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...
‘Remarkable AI’ Finds Lung Cancer Patients Who Respond Well to Immunotherapy
A domestic study has revealed that artificial intelligence can preemptively identify lung cancer patients who can...